NCT02775955View on ClinicalTrials.gov

PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

October 31, 2016

Conditions
Healthy
Interventions
DRUG

RX0041

Active

Trial Locations (1)

08009

Comprehensive Clinical Researc, Berlin

Sponsors
All Listed Sponsors
collaborator

Cognitive Research Corporation

INDUSTRY

lead

Pharmaceutical Project Solutions, Inc.

INDUSTRY